Stopped early
Registry of the Magellan Robotic System
NCT01984437 · Hansen Medical · Updated 1 March 2018
- What is being tested
- Not stated
- For
- Peripheral Vascular Disease
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 348 people. The full rules are on the registry page.
- Where
- United States, France, Germany (7 sites)
- When
- Starts or started Nov 2013, ends Aug 2016. Registered 14 Nov 2013.
- Results
- None posted yet.
In the researchers' words
The purpose of the registry is to gather both retrospective and prospective case data on the use of the commercially available Magellan Robotic System and Magellan Robotic Catheters in accordance with the approved intended use. For prospective cases, follow-up patient data will be collected at 14 days (± 5 days) post procedure to assess treatment success, primary patency of intended targeted vessel region, and adverse events. The data will be analyzed for medical education, societal presentation, and/or publication by the investigators. Over the next 2+ years, physicians who meet the selection criteria will be invited to participate in the registry.
Sites
- Keck Medical Center of USCLos Angeles, California, United States
- Miami Cardiac & Vascular InstituteMiami, Florida, United States
- Good Samaritan HospitalCincinnati, Ohio, United States
- Miami Valley HospitalDayton, Ohio, United States
- The Methodist HospitalHouston, Texas, United States
- University Hospital of StrasbourgStrasbourg, France
- Herz- und Gefäßzentrum Bad BevensenBad Bevensen, Germany